Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Clinical trial NCT06317649 · RECRUITING
Trial details
- NCT number
- NCT06317649
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-27
- Primary completion
- 2029-05-15
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.